Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ·Healthcare·Biotechnology
$0.88
-0.41%
Mkt Cap $3.01M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 30, 2026 | — | — | — | -$1.08 | -$0.72 | +33.33% | — | — |
| Q4 2025 Nov 13, 2025 | — | — | — | -$0.11 | -$0.06 | +45.45% | — | — |
| Q3 2025 Aug 14, 2025 | — | — | — | -$0.15 | -$0.12 | +20.00% | — | — |
| Q2 2025 May 15, 2025 | — | — | — | -$0.21 | -$0.13 | +38.10% | — | — |
| Q1 2025 Mar 31, 2025 | — | — | — | -$0.22 | -$0.15 | +31.82% | — | — |
| Q4 2024 Nov 14, 2024 | — | — | — | -$0.23 | -$0.25 | -8.70% | — | — |
| Q3 2024 Aug 14, 2024 | — | — | — | -$0.28 | -$0.26 | +7.14% | — | — |
| Q2 2024 May 14, 2024 | — | — | — | -$0.28 | -$0.25 | +10.71% | — | — |
| Q2 2024 Apr 15, 2024 | — | — | — | -$0.35 | -$0.35 | +0.00% | — | — |
| Q4 2023 Nov 14, 2023 | — | — | — | -$0.35 | -$0.44 | -25.71% | — | — |
| Q3 2023 Aug 14, 2023 | — | — | — | -$0.29 | -$0.55 | -89.66% | — | — |
| Q2 2023 May 15, 2023 | — | — | — | -$0.36 | -$0.30 | +16.67% | — | — |
| Q1 2023 Mar 30, 2023 | — | — | — | -$0.23 | -$0.38 | -65.22% | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | -$0.30 | -$0.18 | +40.00% | — | — |
| Q3 2022 Aug 15, 2022 | — | — | — | -$0.31 | -$0.29 | +6.45% | — | — |
| Q2 2022 May 16, 2022 | — | — | — | -$0.28 | -$0.40 | -42.86% | — | — |
| Q1 2022 Mar 15, 2022 | — | — | — | -$0.24 | -$0.24 | +0.00% | — | — |
| Q4 2021 Nov 15, 2021 | — | — | — | -$0.25 | -$0.12 | +52.00% | — | — |
| Q3 2021 Aug 16, 2021 | — | — | — | -$0.24 | -$0.12 | +50.00% | — | — |
| Q2 2021 May 17, 2021 | — | — | — | — | -$0.10 | — | — | — |